PT  - JOURNAL ARTICLE
AU  - Bilal Haider Lashari
AU  - Robert J Vender
AU  - Derlis Christian Fleitas-Sosa
AU  - Tejas Sinha
AU  - Gerard J Criner
TI  - Lung cancer in recipients after lung transplant: single-centre experience and literature review
AID  - 10.1136/bmjresp-2021-001194
DP  - 2022 Apr 01
TA  - BMJ Open Respiratory Research
PG  - e001194
VI  - 9
IP  - 1
4099  - http://bmjopenrespres.bmj.com/content/9/1/e001194.short
4100  - http://bmjopenrespres.bmj.com/content/9/1/e001194.full
SO  - BMJ Open Resp Res2022 Apr 01; 9
AB  - Introduction Lung cancer is a major challenge facing modern medicine. It is the leading cause of cancer-related death in the USA. Little is known of the incidence, prevalence and disease characteristics in lung transplant recipients, a population unique in its vulnerability and exposure to carcinogenic risk factors. We aimed to elaborate these characteristics of lung cancer in our population through a retrospective cohort study.Methods We retrospectively reviewed our institution’s 8-year experience with lung transplantation and searched for patients with a post-transplant diagnosis of lung cancer, neoplasia or mass. We focused on patient demographics, indication for transplant, smoking history, stage at diagnosis, location of the tumour, length of time between transplant and diagnosis, the treatment offered and length of time from diagnosis to death or last follow-up. Descriptive statistics and survival analysis standard Kaplan-Meier method was conducted from the date of cancer diagnosis to death from all-cause mortality or last follow-up as of August 2021.Results We identified 24 patients with de novo lung cancer postlung transplant in 905 recipients. More patients with an underlying diagnosis of idiopathic pulmonary fibrosis developed lung cancer. Twenty-one patients were diagnosed with non-small cell lung cancer and three had small cell lung cancer. The remaining native lung was involved most in single lung recipients with 17 patients. Patients with a diagnosis of lung cancer had a mean survival of 17.6 months after diagnosis.Discussion The incidence rate of lung cancer in our cohort was higher than reported for smokers from the general population in previous studies. In this study, we compare our findings with available literature. We also explore screening strategies, treatment modalities, survival and postulated mechanisms for the development of lung cancer in lung transplant recipients.No data are available.